Direct-Acting Antiviral Initiation Among People With Hepatitis C Virus (HCV) and HIV on Antiretroviral Therapy in the United States and Canada: Factors Driving the HCV Treatment Gap - Poll - MDSpire

Direct-Acting Antiviral Initiation Among People With Hepatitis C Virus (HCV) and HIV on Antiretroviral Therapy in the United States and Canada: Factors Driving the HCV Treatment Gap

  • By

  • Raynell Lang

  • Elizabeth Humes

  • Asya Lyass

  • Leila H Borowsky

  • Brenna Hogan

  • Arthur Kim

  • Michael LaValley

  • Michael J Silverberg

  • H Nina Kim

  • Sonia Napravnik

  • Richard D Moore

  • Michael A Horberg

  • Frank J Palella

  • Greg D Kirk

  • Edward Cachay

  • George A Yendewa

  • Seble Kassaye

  • Kathleen McGinnis

  • Sally B Coburn

  • Timothy R Sterling

  • Marina B Klein

  • Mari M Kitahata

  • Catherine Lesko

  • Virginia A Triant

  • Keri N Althoff

  • on behalf the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of the International Epidemiologic Databases to Evaluate AIDS (IeDEA)

  • August 4, 2025

  • 0 min

Share

Original Source(s)

Direct-Acting Antiviral Initiation Among People With Hepatitis C Virus (HCV) and HIV on Antiretroviral Therapy in the United States and Canada: Factors Driving the HCV Treatment Gap

  • by Raynell Lang, Elizabeth Humes, Asya Lyass, Leila H Borowsky, Brenna Hogan, Arthur Kim, Michael LaValley, Michael J Silverberg, H Nina Kim, Sonia Napravnik, Richard D Moore, Michael A Horberg, Frank J Palella, Greg D Kirk, Edward Cachay, George A Yendewa, Seble Kassaye, Kathleen McGinnis, Sally B Coburn, Timothy R Sterling, Marina B Klein, Mari M Kitahata, Catherine Lesko, Virginia A Triant, Keri N Althoff, on behalf the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of the International Epidemiologic Databases to Evaluate AIDS (IeDEA)

  • August 4, 2025

Related Content

Who Decides When a Doctor Steps Back?

Cognitive decline, credentialing, and why “I’ll know” often isn’t enough.

Development of a Rapid Automated Point-of-Care Test for Hepatitis C Viral RNA on the DASH Rapid Polymerase Chain Reaction System

The Journey to Hepatitis C Elimination in Taiwan: Insights From the Hemodialysis Population